DeepMind's latest AI can foresee genetic illnesses.
September 20 2023
About a decade ago, Žiga Avsec began his journey into genomics as a physics PhD student and is now a research scientist at Google’s DeepMind. He and his team have created AlphaMissense, a machine learning model capable of analysing missense variants (single-letter genetic code changes known to cause diseases like sickle cell anemia and type 2 diabetes) and predicting their likelihood of causing disease with 90% accuracy. The tool, which works like a large language model trained on human biology, assigns a pathogenicity score to each of the 71 million possible missense variants. The score represents the likelihood of a mutation causing disease, helping researchers identify potentially harmful mutations faster. Though the tool is significantly impactful, the team insists that its predictions should complement real-world research rather than replacing it.
Back to Breaking AI News
What does it mean?
- Genomics: The study of all of a person's genes (the genome), including interactions of those genes with each other and with the person's environment.
- Research Scientist: An individual who conducts scientific research to advance knowledge in an area of interest.
- DeepMind: A British artificial intelligence company owned by Alphabet Inc.
- AlphaMissense: A machine learning model developed by Google's DeepMind to analyze missense variants.
- Machine Learning Model: A type of artificial intelligence tool that gets better at a task by learning from data, rather than being explicitly programmed.
- Missense variants: Changes of a single letter in the genetic code that can cause diseases.
- Pathogenicity score: A measure that represents the likelihood of a mutation causing a disease.
Does reading the news feel like drinking from the firehose?
Do you want more curation and in-depth content?
Then, perhaps, you'd like to subscribe to the Synthetic Work newsletter.
Many business leaders read Synthetic Work, including:
CEOs
CIOs
Chief Investment Officers
Chief People Officers
Chief Revenue Officers
CTOs
EVPs of Product
Managing Directors
VPs of Marketing
VPs of R&D
Board Members
and many other smart people.
They are turning the most transformative technology of our times into their biggest business opportunity ever.
What about you?
Do you want more curation and in-depth content?
Then, perhaps, you'd like to subscribe to the Synthetic Work newsletter.
Many business leaders read Synthetic Work, including:
CEOs
CIOs
Chief Investment Officers
Chief People Officers
Chief Revenue Officers
CTOs
EVPs of Product
Managing Directors
VPs of Marketing
VPs of R&D
Board Members
and many other smart people.
They are turning the most transformative technology of our times into their biggest business opportunity ever.
What about you?